3.26.1 html 330 295 1 true 92 0 false 4 false false R1.htm 000 - Document - Document And Entity Information Sheet http://revivapharma.com/20251231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://revivapharma.com/20251231/role/statement-consolidated-balance-sheets Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://revivapharma.com/20251231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://revivapharma.com/20251231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://revivapharma.com/20251231/role/statement-consolidated-statement-of-stockholders-equity Consolidated Statement of Stockholders' Equity Statements 5 false false R6.htm 005 - Statement - Consolidated Statements of Cash Flows Sheet http://revivapharma.com/20251231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 995443 - Disclosure - Award Timing Disclosure Sheet http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure Award Timing Disclosure Notes 7 false false R8.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 8 false false R9.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 9 false false R10.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 10 false false R11.htm 995550 - Disclosure - Note 1 - Organization and Nature of Operations Sheet http://revivapharma.com/20251231/role/statement-note-1-organization-and-nature-of-operations Note 1 - Organization and Nature of Operations Notes 11 false false R12.htm 995551 - Disclosure - Note 2 - Summary of Significant Accounting Policies and Basis of Presentation Sheet http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation Note 2 - Summary of Significant Accounting Policies and Basis of Presentation Notes 12 false false R13.htm 995552 - Disclosure - Note 3 - Net Loss Per Share Sheet http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share Note 3 - Net Loss Per Share Notes 13 false false R14.htm 995553 - Disclosure - Note 4 - Warrants Sheet http://revivapharma.com/20251231/role/statement-note-4-warrants- Note 4 - Warrants Notes 14 false false R15.htm 995554 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation Notes 15 false false R16.htm 995555 - Disclosure - Note 6 - Commitments and Contingencies Sheet http://revivapharma.com/20251231/role/statement-note-6-commitments-and-contingencies Note 6 - Commitments and Contingencies Notes 16 false false R17.htm 995556 - Disclosure - Note 7 - Fair Value Measurements Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements Note 7 - Fair Value Measurements Notes 17 false false R18.htm 995557 - Disclosure - Note 8 - Income Taxes Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes Note 8 - Income Taxes Notes 18 false false R19.htm 995558 - Disclosure - Note 9 - Segment Information Sheet http://revivapharma.com/20251231/role/statement-note-9-segment-information Note 9 - Segment Information Notes 19 false false R20.htm 995559 - Disclosure - Note 10 - Subsequent Events Sheet http://revivapharma.com/20251231/role/statement-note-10-subsequent-events Note 10 - Subsequent Events Notes 20 false false R21.htm 995560 - Disclosure - Significant Accounting Policies (Policies) Sheet http://revivapharma.com/20251231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation 21 false false R22.htm 995561 - Disclosure - Note 2 - Summary of Significant Accounting Policies and Basis of Presentation (Tables) Sheet http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation-tables Note 2 - Summary of Significant Accounting Policies and Basis of Presentation (Tables) Tables http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation 22 false false R23.htm 995562 - Disclosure - Note 3 - Net Loss Per Share (Tables) Sheet http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share-tables Note 3 - Net Loss Per Share (Tables) Tables http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share 23 false false R24.htm 995563 - Disclosure - Note 4 - Warrants (Tables) Sheet http://revivapharma.com/20251231/role/statement-note-4-warrants-tables Note 4 - Warrants (Tables) Tables http://revivapharma.com/20251231/role/statement-note-4-warrants- 24 false false R25.htm 995564 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation (Tables) Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-tables Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation (Tables) Tables http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation 25 false false R26.htm 995565 - Disclosure - Note 7 - Fair Value Measurements (Tables) Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-tables Note 7 - Fair Value Measurements (Tables) Tables http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements 26 false false R27.htm 995566 - Disclosure - Note 8 - Income Taxes (Tables) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-tables Note 8 - Income Taxes (Tables) Tables http://revivapharma.com/20251231/role/statement-note-8-income-taxes 27 false false R28.htm 995567 - Disclosure - Note 1 - Organization and Nature of Operations (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-1-organization-and-nature-of-operations-details-textual Note 1 - Organization and Nature of Operations (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-1-organization-and-nature-of-operations 28 false false R29.htm 995568 - Disclosure - Note 2 - Summary of Significant Accounting Policies and Basis of Presentation (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation-details-textual Note 2 - Summary of Significant Accounting Policies and Basis of Presentation (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation-tables 29 false false R30.htm 995569 - Disclosure - Note 2 - Summary of Significant Accounting Policies and Basis of Presentation - Components of Cash and Cash Equivalents (Details) Sheet http://revivapharma.com/20251231/role/statement-note-2-summary-of-significant-accounting-policies-and-basis-of-presentation-components-of-cash-and-cash-equivalents-details Note 2 - Summary of Significant Accounting Policies and Basis of Presentation - Components of Cash and Cash Equivalents (Details) Details 30 false false R31.htm 995570 - Disclosure - Note 3 - Net Loss Per Share (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share-details-textual Note 3 - Net Loss Per Share (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share-tables 31 false false R32.htm 995571 - Disclosure - Note 3 - Net Loss Per Share - Schedule of Earnings Per Share (Details) Sheet http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share-schedule-of-earnings-per-share-details Note 3 - Net Loss Per Share - Schedule of Earnings Per Share (Details) Details 32 false false R33.htm 995572 - Disclosure - Note 3 - Net Loss Per Share - Antidilutive Securities (Details) Sheet http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share-antidilutive-securities-details Note 3 - Net Loss Per Share - Antidilutive Securities (Details) Details 33 false false R34.htm 995573 - Disclosure - Note 3 - Net Loss Per Share - Antidilutive Securities (Details) (Parentheticals) Sheet http://revivapharma.com/20251231/role/statement-note-3-net-loss-per-share-antidilutive-securities-details-parentheticals Note 3 - Net Loss Per Share - Antidilutive Securities (Details) (Parentheticals) Details 34 false false R35.htm 995574 - Disclosure - Note 4 - Warrants (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-4-warrants-details-textual Note 4 - Warrants (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-4-warrants-tables 35 false false R36.htm 995575 - Disclosure - Note 4 - Warrants - Warrants Outstanding (Details) Sheet http://revivapharma.com/20251231/role/statement-note-4-warrants-warrants-outstanding-details Note 4 - Warrants - Warrants Outstanding (Details) Details 36 false false R37.htm 995576 - Disclosure - Note 4 - Warrants - Summary of Valuation Assumption (Details) Sheet http://revivapharma.com/20251231/role/statement-note-4-warrants-summary-of-valuation-assumption-details Note 4 - Warrants - Summary of Valuation Assumption (Details) Details 37 false false R38.htm 995577 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-details-textual Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-tables 38 false false R39.htm 995578 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Details) Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-summary-of-common-stock-reserved-for-future-issuance-details Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Summary of Common Stock Reserved for Future Issuance (Details) Details 39 false false R40.htm 995579 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Valuation Assumptions (Details) Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-valuation-assumptions-details Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Valuation Assumptions (Details) Details 40 false false R41.htm 995580 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Stock Option Activity (Details) Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-stock-option-activity-details Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Stock Option Activity (Details) Details 41 false false R42.htm 995581 - Disclosure - Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Stock-based Compensation Expense (Details) Sheet http://revivapharma.com/20251231/role/statement-note-5-stockholders-equity-equity-incentive-plans-and-stockbased-compensation-stockbased-compensation-expense-details Note 5 - Stockholders' Equity, Equity Incentive Plans, And Stock-Based Compensation - Stock-based Compensation Expense (Details) Details 42 false false R43.htm 995582 - Disclosure - Note 6 - Commitments and Contingencies (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-6-commitments-and-contingencies-details-textual Note 6 - Commitments and Contingencies (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-6-commitments-and-contingencies 43 false false R44.htm 995583 - Disclosure - Note 7 - Fair Value Measurements (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-details-textual Note 7 - Fair Value Measurements (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-tables 44 false false R45.htm 995584 - Disclosure - Note 7 - Fair Value Measurements - Fair Value on Recurring Basis (Details) Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-fair-value-on-recurring-basis-details Note 7 - Fair Value Measurements - Fair Value on Recurring Basis (Details) Details 45 false false R46.htm 995585 - Disclosure - Note 7 - Fair Value Measurements - Fair Value on Recurring Basis Unobservable Input Reconciliation (Details) Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-fair-value-on-recurring-basis-unobservable-input-reconciliation-details Note 7 - Fair Value Measurements - Fair Value on Recurring Basis Unobservable Input Reconciliation (Details) Details 46 false false R47.htm 995586 - Disclosure - Note 7 - Fair Value Measurements - Fair Value on Recurring Basis Unobservable Input Reconciliation (Details) (Parentheticals) Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-fair-value-on-recurring-basis-unobservable-input-reconciliation-details-parentheticals Note 7 - Fair Value Measurements - Fair Value on Recurring Basis Unobservable Input Reconciliation (Details) (Parentheticals) Details 47 false false R48.htm 995587 - Disclosure - Note 7 - Fair Value Measurements - Key Inputs (Details) Sheet http://revivapharma.com/20251231/role/statement-note-7-fair-value-measurements-key-inputs-details Note 7 - Fair Value Measurements - Key Inputs (Details) Details 48 false false R49.htm 995588 - Disclosure - Note 8 - Income Taxes (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-details-textual Note 8 - Income Taxes (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-8-income-taxes-tables 49 false false R50.htm 995589 - Disclosure - Note 8 - Income Taxes - Domestic and International Pre-tax Income (Loss) (Details) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-domestic-and-international-pretax-income-loss-details Note 8 - Income Taxes - Domestic and International Pre-tax Income (Loss) (Details) Details 50 false false R51.htm 995590 - Disclosure - Note 8 - Income Taxes - Income Tax Expense Attributable to Operations (Details) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-income-tax-expense-attributable-to-operations-details Note 8 - Income Taxes - Income Tax Expense Attributable to Operations (Details) Details 51 false false R52.htm 995591 - Disclosure - Note 8 - Income Taxes - Provision for Income Taxes (Details) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-provision-for-income-taxes-details Note 8 - Income Taxes - Provision for Income Taxes (Details) Details 52 false false R53.htm 995592 - Disclosure - Note 8 - Income Taxes - Deferred Tax Assets (Details) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-deferred-tax-assets-details Note 8 - Income Taxes - Deferred Tax Assets (Details) Details 53 false false R54.htm 995593 - Disclosure - Note 8 - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) Sheet http://revivapharma.com/20251231/role/statement-note-8-income-taxes-schedule-of-unrecognized-tax-benefits-details Note 8 - Income Taxes - Schedule of Unrecognized Tax Benefits (Details) Details 54 false false R55.htm 995594 - Disclosure - Note 9 - Segment Information (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-9-segment-information-details-textual Note 9 - Segment Information (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-9-segment-information 55 false false R56.htm 995595 - Disclosure - Note 10 - Subsequent Events (Details Textual) Sheet http://revivapharma.com/20251231/role/statement-note-10-subsequent-events-details-textual Note 10 - Subsequent Events (Details Textual) Details http://revivapharma.com/20251231/role/statement-note-10-subsequent-events 56 false false All Reports Book All Reports rvph-20251231.xsd rvph-20251231_cal.xml rvph-20251231_def.xml rvph-20251231_lab.xml rvph-20251231_pre.xml rvph20251231_10k.htm fig02.jpg fig03.jpg fig04.jpg fig05a.jpg fig05b.jpg fig05c.jpg fig05d.jpg fig06.jpg fig07a.jpg fig07b.jpg fig07c.jpg fig08.jpg fig09.jpg fig10.jpg fig11.jpg fig12.jpg fig14.jpg fig15.jpg figure_13.jpg reviva.jpg table03.jpg table04.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true